Me Line: Melasma management kit from Aakaar “Pioneers in Indian Aesthetics”

Aakaar Medical Technologies Pvt Ltd previously known as Coherent Medical System is a Pioneer Organization in field of Medical Aesthetics and Cosmetics. Aakaar believes that every Indian and their skin deserves best care & treatment. Aakaar believes in quality. Aakaar has launched a variety of innovative and first time in India products to help Aesthetics practitioners improve their clients outcomes. Backed with this philosophy Aakaar in collaboration with INNOAESTHETICS LABORATORIES has launched a specifically developed FIRST AND UNIQUE LINE, SPECIALIZESD FOR PIGMENTATION TREATMENT ESPECIALLY MELASMA MANAGEMENT.

ME LINE comprises optimum concentration of highly-effective actives and employs chemical MICRODERMABRASION MECHANISM to treat the skin steadily yet completely. The Me Line range is a kit of professional care and home care “highly tolerable formulation, specifically designed for Ethnic or Indian Skin.
The products have Optimum concentration of clinically proven ingredients developed over years of research at LABORATORIO
INNOAESTHETICS, SPAIN. Clinical proven for efficacy & devoid of Cytotoxic effects.
Melasma is the most common pigmentary disorder among
Asians. It is common (almost 90% of the cases) in women, especially in their reproductive years, but about 10% of the cases occurs in men. It causes brown to gray-brown patches, usually on the face. Most of the people get it on their cheeks, bridge of nose, forehead, chin, and above upper lip. It also can appear on other parts of the body that get lots of sun, such as the forearms and neck.
So with Launch of Me Line Kit for management of Melasma and their recent successfully launched produt Tubelite for management of Pigment disorders of different causes Aakaar is surely moving strongly forward and is growing strong.
For more information WhatsApp 9930496199.

See also  4rabet Mobile app – Download APK for Android

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button

Adblock Detected

Please consider supporting us by disabling your ad blocker